Avalo Therapeutics: Funding, Investors & Team (Oct 2026)
Avalo Therapeutics is a clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize highly targeted therapeutics in areas of significant unmet clinical need.
Avalo Therapeutics has raised $431M across 1 funding round on record, the most recent an undisclosed round of $431M announced in May 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Avalo Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2026.
Avalo Therapeutics Funding Rounds
Avalo Therapeutics Founders and Leadership Team
Contact details for the Avalo Therapeutics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Avalo Therapeutics Funding Compared to Other Biotechnology Startups
Avalo Therapeutics' latest round of $431M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Avalo Therapeutics in Biotechnology and Rockville
Companies Similar to Avalo Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Avalo Therapeutics Funding FAQs
What does Avalo Therapeutics do?
Avalo Therapeutics is a clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize highly targeted therapeutics in areas of significant unmet clinical need.
How much funding has Avalo Therapeutics raised?
Avalo Therapeutics has raised $431M across 1 round on record. The most recent is an undisclosed round of $431M announced in May 2026.
When did Avalo Therapeutics last raise funding?
Avalo Therapeutics' most recent funding round on record is an undisclosed round of $431M, announced in May 2026.
Who founded Avalo Therapeutics?
FundedIQ lists Garry Neil (Founder) at Avalo Therapeutics.
Where is Avalo Therapeutics headquartered?
Avalo Therapeutics is based in Rockville, Maryland, United States.
How many employees does Avalo Therapeutics have?
Avalo Therapeutics is in the 11-50 employee band.
How does Avalo Therapeutics' funding compare to other Biotechnology startups?
Avalo Therapeutics' latest round of $431M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Avalo Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Avalo Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.